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Summary Plateau-phase Chinese hamster V79 cells were exposed to various concentrations of adriamycin (0-
21upgml-1) in conditioned medium from plateau-phase cultures (C-med). Cells were plated for colony
formation, either immediately after adriamycin treatment or after a 24h incubation either in fresh medium (F-
med) or C-med. A potentiation of cell killing was observed in cells plated 24h after treatments which was
larger for cells incubated in F-med than for cells incubated in C-med. Trypsinization of the cells and replating
for 24h in the same volume of medium (total amounts of cells) but at lower surface density to reduce
intercellular contact, did not modify the killing potentiation observed after delayed plating. Four to 6 changes
of medium, carried out at 1 h intervals, starting immediately after treatment, led to an elimination of the
killing potentiation otherwise found in cells kept after treatment in F-med and resulted in survival levels
similar to those of cells plated immediately after treatment. On the other hand, survival levels higher by a
factor 1.5 to 10 than those obtained for cells plated immediately after treatment were observed for cells kept
in C-med when four medium changes were carried out during the first 5h of the 6 or 24h post-treatment
period. Incubation with 150,M ,B-arabinofuranosyladenine (araA) for 6h (C-med) after exposure to
adriamycin (4 changes of medium at 1 h intervals) prevented the increase in survival observed after incubation
in C-med but also caused an additional potentiation in killing resulting in survival levels lower than those of
cells plated immediately after treatment. These results are interpreted as indicating the induction by
adriamycin of potentially lethal damage (PLD), sensitive to araA, similar to that observed after exposure to
low LET ionizing radiation. Repair and/or fixation of this form of PLD can only be shown if precautions are
taken to circumvent toxicity induced by adriamycin released from the cells during the post-treatment time
interval, for example, by frequent changes in medium.
Anthracyclines, and adriamycin in particular, are radio-
mimetic compounds that find extensive application in the
treatment of a variety of human tumours (Crooke & Reich,
1970). One parameter that affects adriamycin-induced cyto-
toxicity is the proliferation state of the treated population.
Non-growing cells, as for example those cells from cultures
that have reached a plateau-phase, were found to be signifi-
cantly more resistant to adriamycin than their growing
counterparts (Barranco, 1975; Barranco & Novak, 1975;
Twentyman & Bleehen, 1975; Sutherland et al., 1979; Martin
& McNally, 1980; Chambers et al., 1984). Since a significant
amount of non-proliferating cells exist in certain experi-
mental tumours (Mendelsohn, 1965), this difference in
response is likely to have implications in the treatment of
human tumours with a high fraction of non-dividing cells.
It has been proposed that plateau-phase cultures are a
better model to describe a tumour than actively growing
cultures (Hahn & Little, 1972). Additionally, cells in this
phase were found proficient in repairing potentially lethal
damage (PLD) (Phillips & Tolmach, 1966) induced either by
low LET radiation (e.g., Hahn & Little, 1972; Iliakis &
Pohlit, 1979) or other chemotherapeutic drugs (Ray et al.,
1973; Barranco, 1975), if a time interval of a few hours is
allowed to elapse between exposure to the toxic agent and
subculture for colony formation. No evidence for repair of
PLD could be obtained in adriamycin-treated plateau-phase
Chinese hamster cells (Hahn et al., 1975) or plateau-phase
CHO cells (Barranco, 1976), a result that led to the
conclusion that PLD may not be induced after exposure of
cells to this agent.
In a series of experiments designed to study the response
to adriamycin, and the effect ofdelayed-plating in particular,
of plateau-phase Chinese hamster V79 cells (Iliakis et al.,
1986), a dramatic potentiation in killing was observed in
cells replated several hours after treatment. This effect could
not be explained by increased drug accumulation or
retention by cells in the plateau-phase and implied action of
biological mechanisms entirely different from those involved
in the repair of PLD. In this paper we report a set of
experiments that identify drug release by the cells in the
culture medium during the post-treatment incubation period
as the cause of the potentiation in killing observed. Further-
more, we show that when precautions are taken to prevent
post-treatment drug presence by frequently changing the
medium, an increase in survival can be observed indicating
induction and repair of PLD in cells kept under non-growing
conditions. Exposure of adriamycin treated cells to the DNA
polymerases inhibitor ,B-arabinofuranosyladenine (araA)
(Muller et al., 1985; Okura & Yoshida, 1978) resulted in a
potentiation in cell killing. This finding supports the
hypothesis that DNA may be a target for adriamycin-
induced cell killing (Rupniak et al., 1983) and indicates
induction and repair of PLD in way similar to that observed
after exposure to ionizing radiation (Iliakis, 1980, 1981).
Materials and methods
For the experiments, Chinese hamster V79 cells (S171) were
used. Details about their origin and growth conditions have
been published (Iliakis, 1985). Briefly, cells grew at 37°C in a
humidified atmosphere of 5% CO2 in MEM (GIBCO)
supplemented with 15% foetal calf serum (Hazelton). For
the experiments, cells from these cultures were plated at a
concentration of 2x105 cells/dish (50mm, 5ml MEM per
dish) and were used 3 days later. At this time, cells had
reached a plateau-phase with >80% of the cells (compared
to -30% in growing cell populations) accumulated in a
phase showing a DNA content equivalent to that of Gi-cells
(flow cytometry measurements). Adriamycin (Sigma) was
applied to plateau-phase cells for I h (in conditioned medium
from plateau-phase cultures) from a 1 mgml-1 water
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solution (kept frozen) at 37°C. After treatment, cells were
rinsed twice with phosphate buffered saline and either
returned to the incubator after addition of 5ml F-med or
medium gained from replicate plateau-phase cultures after
filtration to remove viable cells (C-med), or were trypsinized
and plated. In some experiments, cells were incubated after
treatment with adriamycin in C-med in the presence off,-
arabinofuranosyladenine (araA, Sigma) added from a 10mM
water solution. Cells were plated to form colonies in two
60mm tissue culture dishes and were incubated at 37°C for
6-7 days. Plating efficiency was between 40-60%. Twenty-
five to 400 colonies were counted per dish, the standard
errors of counting in the estimation of cell survival thus
being between 3-14%. Curves were fitted to the data points
by eye. Results derived from a single experiment are shown.
All results have been confirmed in 2-4 independent
experiments.
Results
Survival curves of cells exposed to various concentrations of
adriamycin in C-med for 1 h and plated either immediately
or after a 24h incubation in F-med under various conditions
are shown in Figure 1. Cells plated immediately after treat-
ment (IP, open triangles) showed a biphasic response with an
initial rapid decrease in survival followed by a resistant tail
with a slope of 0.11+0.Olml/ig- . Incubation of cells for
24h in F-med before plating (DP, closed circles) caused a
potentiation of killing and resulted in a survival curve with
an initial slope of 2.0+0.3mlyg-1 (Iliakis et al., 1986). In
order to test whether cell-to-cell contact, as present in
plateau-phase cultures, affected the observed potentiation of
killing, cells were trypsinized immediately after treatment,
resuspended in 5 ml F-med (total amount of cells), and
incubated in 100mm tissue culture dishes, to decrease surface
density, for 24h. No difference was observed in response
between cells trypsinized after irradiation (open circles) as
compared to cells left in the confluent state. Increased killing
could result from post-treatment release of adriamycin from
the cells that affected the survivors during the long post-
treatment incubation. To test this, replicate cultures were
Plateau-phase V79-cells
treated with various doses of adriamycin and returned to the
incubator after medium change (F-med). At I h intervals
thereafter, medium was exchanged with fresh adriamycin-
free medium kept at 37°C and 5% CO2. A significant
reduction in the potentiation of killing, dependent on the
number of medium changes performed, was observed under
these conditions. Four changes in medium performed hourly
at the beginning of the 24h incubation period essentially
reversed the potentiation in killing usually observed (DP,
closed triangles). After 6 changes in medium, cell survival
was indistinguishable from that observed with cells plated
immediately after treatment (DP, inverted closed triangles)
and it was not further modified by an increase in the number
of medium changes (open inverted triangles in the figure
show results obtained after 8 medium changes).
Similar results were also obtained after treatment and
post-treatment incubation in C-med (Figure 2). Cells plated
immediately after treatment (IP, open triangles) showed a
biphasic survival curve, and incubation of cells for 24h in C-
med resulted in a potentiation of killing (DP, closed
triangles). Changes in medium during the first few hours of
post-treatment incubation (C-med was used throughout the
experiment) resulted in a reduction in the killing potentiation
otherwise observed and cell survival reached a maximum
after about 4 medium changes. It is interesting, however,
that the survival levels reached in this case were significantly
higher (DP, closed inverted triangles) than those observed
for cells either plated immediately after treatment (open
circles) or kept in F-med with frequent changes of medium
(see Figure 1). This response is similar to the response of
plateau-phase cells to ionizing radiations and can be
tentatively interpreted as indicating repair of adriamycin-
induced PLD. There was no difference in the survival levels
reached with cells plated 6 or 24h after treatment, thus
suggesting that the assumed repair activity must be
completed within about 6h.
To further establish whether the increase in survival
observed in cells kept in the plateau-phase under growth
inhibiting conditions (C-med) may be attributed to repair
reactions similar to those observed after radiation exposure,
a set of cultures was treated with various doses of adria-
mycin in C-med for 1 h and subsequently incubated with
150 iM araA for 6h. The same post-treatment protocol was
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Figure 1 Survival of cells exposed to various doses of
adriamycin in C-med for 1 hr and replated for colony formation:
(a) immediately thereafter (A); (b) after 24h incubation in F-
med (0); (c) after 24h incubation in F-med after replating at a
lower surface density (0); (d) after 24h incubation in F-med,
but with 4 changes in medium during the first 5hr (A); (e) after
24h incubation in F-med, but with 6 changes in medium during
the first 7h (V); (f) after 24h incubation in F-med, but with 8
changes in medium during the first 9h (V).
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Figure 2 Survival of cells exposed to various doses of
adriamycin in C-med for 1 h and replated for colony formation:
(a) immediately thereafter (A); (b) after 24h incubation in C-
med (A); (c) after 6h incubation in C-med, but with 4 changes
in medium during the first 5h (0); (d) after 24h incubation in
C-med, but with 4 changes in medium during the first 5 h (7);
(e) after 6h incubation in C-med in the presence of 150juM araA
but with 4 changes in medium during the first 5 h (0).
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used for the delayed plated cells and medium was changed 4
times during the first 4h, with C-med containing araA at the
concentration used. A potentiation of killing was observed
under these conditions and the survival levels reached were
lower than those obtained with cells plated immediately after
treatment (closed circles). This observation indicated that
post-treatment incubation with araA not only caused inhi-
bition of the increase in survival (above the immediate
plating level) usually observed under these conditions (open
circles, i.e., inhibition of PLD-repair), but that it also caused
fixation of damage (PLD) that would normally have been
repaired in cells plated immediately after treatment.
Discussion
The results presented indicate that drug release from
adriamycin-treated cells may potentiate killing after delayed
plating. Cell-to-cell contact does not appear to play a
significant role in this effect since similar survival curves
were obtained with cells trypsinized and plated at a lower
surface density after treatment. The concentrations of adria-
mycin reached through drug release were probably lower
compared to those initially applied, but due to the prolonged
exposure a significant amount of killing was induced. Based
on an accumulation (spectralfluorometric measurements) of
0.35pg adriamycin per 106 cells after a 1 h exposure to
lOpgm1-1, a concentration of 0.55jgmP-1 could be
maximally achieved if the total amount of intracellular adria-
mycin (8 x 106 cells/dish) was released in the medium (5ml).
This interpretation is supported by the observation that
frequent changes of medium during the first 4-6h after
treatment led to a reduction or elimination of the killing
potentiation observed. It is interesting that this 4-6h time
frame compares well with the observation that adriamycin-
release in plateau-phase cells kept in F-med or C-med,
reached a plateau after - 4h (Iliakis et al., 1986). The
continuing cytotoxicity induced by released adriamycin also
explains why the enhancement in killing observed did not
reach a plateau even 20-24h after treatment (Iliakis et al.,
1986).
A larger proliferation of killing was found in cells in-
cubated in F-med versus cells incubated in C-med. This
difference in response is presumably due to the induction of
proliferation caused after incubation of cells in F-med (one
division in 24h), which is known to render cells more
sensitive to adriamycin (Barranco, 1975; Twentyman &
Bleehen, 1975; Barranco & Novak, 1976; Sutherland et al.,
1979; Iliakis et al., 1986). Differences in the proliferation
state of the cell population may also explain the difference
between this report and a previous report (Iliakis et al.,
1986) and may also explain the lack of killing potentiation
reported in other cell lines for post-treatment incubation of
- 6h (Hahn et al., 1975; Barranco, 1976).
It is interesting that when released adriamycin was
removed by frequent medium changes, survival of cells kept
in F-med was identical to that of cells plated immediately
after treatment, but survival of cells kept in C-med was
higher by almost a factor of 10 at adriamycin concentrations
higher than 15jigml- . This observation suggests induction
by adriamycin of damage that is only potentially lethal
(Philipps & Tolmach, 1966), the repair of which is promoted
under conditions preventing cell progression through the
cycle. It is similar to the repair reported for plateau-phase
cells exposed to low LET radiations and may indicate
involvement of similar mechanisms of killing. Failure to
observe this type of reaction in experiments previously
reported (Hahn et al., 1975; Barranco, 1976) may be related
to residual adriamycin toxicity masking possible increase in
survival. The fact that there was no difference in the survival
levels observed with cells plated 6 or 24h after treatment (4
medium changes in the first 5h) indicates completion of
repair within about 6h, a result similar to that observed
after exposure to X-rays (Hahn & Little, 1972).
Barranco and Townsend (1986) recently reported induc-
tion and repair of adriamycin-induced PLD in exponentially
growing cells from human gastric cancer clones. It is
possible that under these treatment conditions repair of PLD
could be observed without changes in medium during the
post-treatment incubation period, due to the low number of
cells in the culture which reduced the amount of drug
released during the post-treatment incubation period.
Radiation-induced PLD was found to be sensitive to araA,
a DNA polymerase inhibitor (Iliakis, 1980, 1981). These
results indicated that DNA was the locus of PLD induction
and suggested the involvement of DNA polymerization in
the repair and/or fixation reactions. The results obtained
after exposure to adriamycin in the present study are similar
and lead to similar conclusions. Incubation for 4h with
150/M araA caused inhibition of PLD repair usually
observed under conditions delaying cell growth (incubation
in C-med), and caused fixation of PLD normally repaired by
cells plated immediately after irradiation. Thus, repair and/or
fixation of adriamycin-induced PLD was found to cause a 5-
20 fold modulation in cell survival in the dose region
examined. More detailed experiments are required to
establish PLD repair rates as well as the possible existence of
adriamycin-induced sectors of PLD sensitive or resistant to
araA as reported for exposure to y-rays (Iliakis, 1985; Iliakis
et al., 1985).
The specific inhibition by araA of DNA related processes
(Muller et al., 1975; Okura & Yoshida, 1978) in combination
with the observed effect on cell survival, indicates DNA as a
target for adriamycin, at least for the fraction of damage
whose expression resulted in the variation in survival
observed, although the existence of other targets as well
cannot be excluded (Triton & Yee, 1982).
In summary, the results presented suggested induction by
adriamycin of araA-sensitive PLD whose repair and/or
expression was shown when precautions were taken to
circumvent toxicity induced by adriamycin released from the
cells during the post-treatment incubation period.
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